Meredith Wetzel

1. A Randomized Phase II Study: CRS207/GVAX plus Anti–PD-1 and Anti-CTLA4 Recruits Mesothelin- and mKRAS-Specific T Cells into PDAC
   2026/01/12 by Katherine M. Bever, Amanda Huff, Ludmila Danilova +16 · 1 voice
   Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Immunotherapy and Immune Responses #Pancreatic and Hepatic Oncology Research #vaccines and immunoinformatics approaches